I loving shopping at Target. Learn how to save more money at Target by finding bargains within their clearance sections. Find ...

Ameluz-photodynamic therapy in superficial basal cell carcinoma may improve the clearance of target lesions, as shown in ...

Cipla share price had fallen after the company's September quarter results as analysts cut their target price, citing weaker than expected domestic business and challenges in its key products.

The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.

Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...

Chevron's strategic moves and positive developments position the company for growth and success, making it a strong choice ...

QIAGEN is expanding its portfolio for QIAstat-Dx in North America, with the recent launch of the QIAstat-Dx Analyzer 2.0, FDA clearance of the Gastrointestinal Panel 2 and submission for FDA clearance ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

The listing rates continued to decline and clearance rates declined more than seasonally typical ... just 50 basis points shy ...

Cipla projects a mid-FY26 launch for Advair, while the release of Abraxane is contingent on regulatory clearance of the company's Goa facility. Respiratory drug Albuterol faces intensifying ...

Brokerage firms have given a mixed reaction to the shares of drug maker CIPLA Ltd. The pharma company announced its results ...

The FDA recently approved a phase 2 clinical trial to investigate the efficacy of leronlimab in patients with relapsed or ...